06 August 2026 | News
Image Courtesy: Public Domain
ForSight Robotics, a global pioneer in robotic eye surgery, announced a significant milestone in the clinical evolution of ophthalmic robotics, demonstrating that fully robotic-assisted cataract surgery can be successfully integrated into the standard clinical workflow of the world's most commonly performed surgical procedure.
Building on the Company's historic first-in-human achievement announced earlier this year, ForSight Robotics has successfully completed an additional 14 fully robotic-assisted cataract surgeries using the JASPER™ Robotic Surgical Platform, bringing its total first-in-human clinical experience to 26 patients. Across all 26 procedures, 100% were successfully completed robotically without conversion to manual surgery. All patients underwent surgery using standard cataract anesthesia protocols, receiving either topical anesthesia alone or mild sedation, consistent with routine clinical practice, and all patients were discharged the same day, consistent with standard outpatient cataract surgery.
"Cataract surgery is performed more than 30 million times each year worldwide, making it the world's most commonly performed surgical procedure," said Joseph Nathan, MD, MSc, co-founder and Chief Executive Officer of ForSight Robotics. "Our first clinical milestone established that fully robotic-assisted cataract surgery was possible. This latest clinical experience demonstrates something even more important: that robotic cataract surgery can integrate naturally into the way cataract surgery is performed every day. This represents a defining milestone, not only for ForSight Robotics, but for the future of ophthalmic surgery."
The procedures were performed as part of the Company's ongoing first-in-human clinical study by Dr. Alexey Rapoport, with Dr. Robert T. Ang, Senior Consultant and Head of the Cornea and Refractive Surgery Services at the Asian Eye Institute, as Principal Investigator of the study.
"One of the most encouraging aspects of this clinical experience has been how seamlessly the robotic platform fits into routine cataract surgery," said Dr. Ang. "Patients underwent surgery using the same anesthesia approaches we use every day, either topical anesthesia alone or mild sedation, and were discharged the same day following standard postoperative care. The robotic platform complemented, rather than disrupted, the normal clinical workflow while providing exceptional precision, stability, and control."
JASPER™ is the world's first robotic surgical platform designed to perform the complete cataract procedure through intuitive surgeon-controlled telemanipulation. The platform combines bimanual robotic manipulation, high-definition three-dimensional visualization, real-time eye tracking, motion scaling, tremor elimination, and advanced computer vision technologies to enhance surgical precision while maintaining the surgeon's control throughout every step of the procedure.
The expanded first-in-human clinical experience represents another important milestone as ForSight Robotics advances toward clinical studies and regulatory submissions. By demonstrating compatibility with the standard workflow of cataract surgery, including routine anesthesia practices, same-day outpatient care, and consistent robotic execution, the Company continues to build evidence supporting the adoption of robotic technology in ophthalmology.
"Our vision extends beyond robotics," added Nathan. "We believe robotic platforms will become the foundation for the next generation of intelligent surgery. By integrating seamlessly into today's clinical practice, we are building the platform that will enable the future evolution of AI-enabled surgical capabilities in the operating room."
